Literature DB >> 11297681

Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein.

Paul Potter1, Sophie Tourdot1, Tom Blanchard2, Geoffrey L Smith2, Keith G Gould1.   

Abstract

The influenza virus strains A/NT/60/68 and A/PR/8/34 both have an immunodominant D(b)-restricted epitope in their nucleoprotein (NP) at amino acid residues 366-374, with two amino acid differences between the epitopes. Cross-reactive cytotoxic T lymphocytes (CTLs) were generated by priming mice with the influenza virus A/NT/60/68 NP and restimulating in vitro with influenza virus A/PR/8/34. CTLs that gave high levels of specific lysis recognized target cells infected with either strain of influenza virus with similar efficiency. Surprisingly, when target cells were infected with recombinant vaccinia viruses (VV) expressing the two different NPs, presentation of the D(b)-restricted epitope from the A/NT/60/68 NP was extremely poor, whereas presentation of the equivalent epitope from the A/PR/8/34 NP was as efficient as in influenza virus-infected cells. This difference was observed in spite of the fact that the two NP sequences show 94% identity at the amino acid sequence level. Experiments with additional cross-reactive CTL cell lines which recognized target cells less efficiently revealed a similar difference in presentation between the two NP epitopes in influenza virus-infected cells and showed a difference in the efficiency of presentation of the D(b)-restricted epitope from the two NP molecules independent of VV infection. The results show that two equivalent epitopes in highly similar proteins are processed with very different efficiency, even though they are both immunodominant epitopes. They also suggest that the previously described inhibition of antigen presentation by VV is a general, non-specific effect, which is more apparent for epitopes that are processed and presented less efficiently.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297681     DOI: 10.1099/0022-1317-82-5-1069

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  5 in total

1.  Novel origin of the 1918 pandemic influenza virus nucleoprotein gene.

Authors:  Ann H Reid; Thomas G Fanning; Thomas A Janczewski; Raina M Lourens; Jeffery K Taubenberger
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

2.  Diminished intracellular invariant chain expression after vaccinia virus infection.

Authors:  Nan Wang; Ekkehard Weber; Janice S Blum
Journal:  J Immunol       Date:  2009-07-10       Impact factor: 5.422

3.  Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response.

Authors:  Karen Buttigieg; Stephen M Laidlaw; Craig Ross; Marc Davies; Stephen Goodbourn; Michael A Skinner
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

4.  Enhancement of DNA Vaccine-induced Immune Responses by Influenza Virus NP Gene.

Authors:  So Young Choi; You Suk Suh; Jae Ho Cho; Hyun Tak Jin; Jun Chang; Young Chul Sung
Journal:  Immune Netw       Date:  2009-10-30       Impact factor: 6.303

Review 5.  Universal influenza vaccines: from viruses to nanoparticles.

Authors:  Ye Wang; Lei Deng; Sang-Moo Kang; Bao-Zhong Wang
Journal:  Expert Rev Vaccines       Date:  2018-11-02       Impact factor: 5.217

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.